Sustained Renal Response to Mycophenolate Mofetil  and CNI Taper Promotes Survival in Liver Transplant Patients  with CNI-Related Renal Dysfunction

Sustained Renal Response to Mycophenolate Mofetil and CNI Taper Promotes Survival in Liver Transplant Patients with CNI-Related Renal Dysfunction

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : A. Kornberg B. Ku¨pper K. Thrum B. Krause P. Bu¨chler J. Kornberg A. Sappler A. Altendorf-Hofmann J. Wilberg H. Friess
  • چاپ و سال / کشور: 2010

Description

Aim The aim of this trial was to evaluate the impact of conversion from a calcineurin-inhibitor (CNI)-based immunosuppressive regimen to mycophenolate mofetil (MMF) and reduced-dose CNI on long-term renal function and survival in a series of 63 liver transplant patients with CNI-induced renal dysfunction. Methods CNI dosage was significantly tapered after introduction of 2,000 mg MMF per day. Renal function was assessed by determination of serum creatinine levels and calculated creatinine clearance (CCl). The impact of relevant clinical parameters on renal function and survival post-conversion was analyzed by univariate and multivariate analysis. Results At 60 months post-conversion, mean creatinine level had significantly declined from 197.2 ± 58.3 lmol/l at baseline to 160.0 ± 76.5 lmol/l, and mean CCl has significantly increased from 38.4 ± 13.4 ml/min at baseline to 47.9 ± 21.1 ml/min (p\0.001), respectively. Forty-six patients (73.1%) demonstrated sustained renal response to modified immunosuppression. Full-dose MMF medication (p = 0.006) and the early conversion (p = 0.02) were identified as independent predictors of persistent renal function improvement. Sustained renal response to MMF plus reduced-dose CNI was identified as the most relevant independent promoter of long-term survival (hazard ratio 6.9). Five-year survival rate post-conversion was 93.9% in renal responders and 64.3% in renal nonresponders (log rank\0.001). Conclusions Sustained renal response to MMF and CNI dose reduction promotes long-term survival in liver transplant patients with CNI-induced renal dysfunction.
Dig Dis Sci (2011) 56:244–251 DOI 10.1007/s10620-010-1386-z Received: 11 June 2010 / Accepted: 4 August 2010 / Published online: 8 September 2010
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری